Revance Therapeutics Overview

Life ScienceCompany

Was Revance Therapeutics formerly PE-backed?

Yes. Revance Therapeutics was formerly owned by 1 private investor.

Where is Revance Therapeutics headquartered?

Revance Therapeutics is headquartered in Newark, California.

What is Revance Therapeutics’ revenue?

Revance Therapeutics disclosed revenue of 234M USD for 2023 and 133M USD for 2022.

What sector is Revance Therapeutics in?

Revance Therapeutics is a life science company.

When was Revance Therapeutics founded?

Revance Therapeutics was founded in 1999.

Revance Therapeutics

Revance Therapeutics, Inc.

1222 Demonbreun Street, Suite 2000,
Newark, California 37203
United States,
(510) 742-3400
www.revance.com

Revance Therapeutics is a specialty biopharmaceutical company focused on the development, manufacturing, and commercialization of novel botulinum toxin products for aesthetic and therapeutic categories. Revance Therapeutics was founded in 1999 and is based in Newark, California.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.